What is the ticker symbol for Altamira Therapeutics?

Altamira Therapeutics trades under the ticker EARS on NASDAQ.

What sector does Altamira Therapeutics operate in?

Altamira Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EARS in a portfolio?

PortView shows EARS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Altamira Therapeutics (EARS) Stock Analysis

NASDAQHealthcareBiotechnology

$3.05-1.77%

52-week range$3.05

$0.73$6.60

What Altamira Therapeutics does

The company is dedicated to creating innovative therapeutic solutions for pressing medical requirements within neurotology and central nervous system disorders. Based in Zug, Switzerland, the firm operates with a modest team of 11 full-time employees. A significant part of its developmental pipeline focuses on intranasal betahistine, specifically AM-125 for addressing vertigo and AM-201 for mitigating antipsychotic-induced weight gain and somnolence. Both betahistine programs are currently in their initial Phase 1 clinical trial stage. Beyond these, the company's product portfolio includes several other promising candidates. Among them are AM-111, a brimapitide-based compound targeting acute inner ear hearing loss, and Keyzilen (AM-101), an eskatemine-based treatment for acute inner ear tinnitus; both are advanced to Phase 3 clinical trials. Additionally, AM-102, another potential treatment for tinnitus, is undergoing preclinical evaluation aimed at identifying the optimal lead compound. The company maintains its operational presence through subsidiary entities located in Switzerland, Ireland, and the United States.

Key metrics

Market cap

$4.21M

P/E (TTM)

-2.05

EPS (TTM)

$-1.48

Beta

1.40

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.25

200-day avg

$3.40

52-week high

$6.60

52-week low

$0.73

CEO

Thomas Meyer

ETFs linked to EARS

Broad-market and Healthcare sector ETFs an investor holding Altamira Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how EARS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EARS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Altamira Therapeutics?: Altamira Therapeutics trades under the ticker EARS on NASDAQ.
Which exchange is EARS listed on?: EARS is listed on NASDAQ.
What sector does Altamira Therapeutics operate in?: Altamira Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EARS in a portfolio?: PortView shows EARS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.